Literature DB >> 15567508

Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization.

E Kleemann1, L A Dailey, H G Abdelhady, T Gessler, T Schmehl, C J Roberts, M C Davies, W Seeger, T Kissel.   

Abstract

Polyelectrolyte complexes between DNA and polyethylenimine (PEI) are promising non-viral delivery systems for pulmonary inhalation gene therapy and thus require sufficient stability during nebulization. The structure and stability of four different PEI-DNA polyplexes, namely branched (bPEI), linear (linPEI), poly(ethylene glycol)-grafted PEI (PEGPEI), biodegradable (bioPEI) PEI with DNA, were investigated. Using atomic force microscopy, the morphology of DNA and polyplexes before and after both air-jet and ultrasonic nebulization was characterized. The influence of nebulization on physico-chemical properties, particle size and zeta potential, was studied. Efficient DNA condensation to spherical particles was achieved with bPEI (90 nm) and PEGPEI (110 nm). By contrast, incomplete DNA condensations, seen as flower structures, were observed with linPEI (110 nm) and bioPEI (105 nm). Air-jet nebulization altered the polyplex structure to a greater extent than ultrasonic nebulization and resulted mainly in smaller and non-spherical particles (30-200 nm). Ultrasonic nebulization did not change the spherical structure or particle size of the polyplexes. In particular, the shape and size of the PEGPEI polyplexes did not change. We conclude that ultrasonic nebulization is a milder aerosolization method for gene delivery systems based on PEI. Additionally, PEGPEI-DNA polyplexes seem to be more stable than their counterparts, which may be advantageous in pulmonary inhalation gene therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567508     DOI: 10.1016/j.jconrel.2004.09.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Synergistic effect of ultrasound and PEI on DNA transfection in vitro.

Authors:  Mangesh C Deshpande; Mark R Prausnitz
Journal:  J Control Release       Date:  2006-12-16       Impact factor: 9.776

2.  Nanoparticle deposition onto biofilms.

Authors:  J K Miller; R Neubig; C B Clemons; K L Kreider; J P Wilber; G W Young; A J Ditto; Y H Yun; A Milsted; H T Badawy; M J Panzner; W J Youngs; C L Cannon
Journal:  Ann Biomed Eng       Date:  2012-08-10       Impact factor: 3.934

3.  Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Authors:  Elke Kleemann; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Thomas Kissel; Werner Seeger
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

4.  Modeling the response of a biofilm to silver-based antimicrobial.

Authors:  A E Stine; D Nassar; J K Miller; C B Clemons; J P Wilber; G W Young; Y H Yun; C L Cannon; J G Leid; W J Youngs; A Milsted
Journal:  Math Biosci       Date:  2013-04-27       Impact factor: 2.144

5.  Structure and biological activity of pathogen-like synthetic nanomedicines.

Authors:  Orsolya Lőrincz; Enikő R Tőke; Eszter Somogyi; Ferenc Horkay; Preethi L Chandran; Jack F Douglas; János Szebeni; Julianna Lisziewicz
Journal:  Nanomedicine       Date:  2011-08-10       Impact factor: 5.307

Review 6.  siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?

Authors:  Aditi Mehta; Thomas Michler; Olivia M Merkel
Journal:  Adv Healthc Mater       Date:  2021-01-27       Impact factor: 11.092

7.  Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization.

Authors:  Anushi E Rajapaksa; Jenny J Ho; Aisha Qi; Rob Bischof; Tri-Hung Nguyen; Michelle Tate; David Piedrafita; Michelle P McIntosh; Leslie Y Yeo; Els Meeusen; Ross L Coppel; James R Friend
Journal:  Respir Res       Date:  2014-05-20

8.  Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.

Authors:  Juliane Nguyen; Terry W J Steele; Olivia Merkel; Regina Reul; Thomas Kissel
Journal:  J Control Release       Date:  2008-06-19       Impact factor: 9.776

9.  Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

Authors:  Peter Järver; Thibault Coursindel; Samir El Andaloussi; Caroline Godfrey; Matthew Ja Wood; Michael J Gait
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-12       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.